Baseline characteristics

Study of Single Agent Belantamab Mafodotin Versus Pomalidomide Plus Low-dose Dexamethasone (Pom/Dex) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) · Source last updated 2026-07-01

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms

1. counts

   1. group Id

      BG000

      value

      218

   2. group Id

      BG001

      value

      107

   3. group Id

      BG002

      value

      325

   units

   Participants

groups

1. description

   Participants with relapsed/refractory multiple myeloma (RRMM) received 30 minutes intravenous infusion of 2.5 milligram/kilogram (mg/kg) belantamab mafodotin on day 1 of each 21-day cycle

   id

   BG000

   title

   Belantamab Mafodotin

2. description

   Participants with RRMM received 4 mg pomalidomide capsule daily on Days 1 to 21 of each 28-day cycle, along with 40 mg or at lower 20 mg (for participants \>75 years of age) dose of dexamethasone tablet once weekly (Days 1, 8, 15 and 22)

   id

   BG001

   title

   Pomalidomide Plus Dexamethasone

3. description

   Total of all reporting groups

   id

   BG002

   title

   Total

measures

1. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            spread

            9.67

            value

            66.3

         2. group Id

            BG001

            spread

            9.68

            value

            66.6

         3. group Id

            BG002

            spread

            9.66

            value

            66.4

   dispersion Type

   STANDARD_DEVIATION

   param Type

   MEAN

   title

   Age, Continuous

   unit Of Measure

   YEARS

2. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            value

            100

         2. group Id

            BG001

            value

            41

         3. group Id

            BG002

            value

            141

         title

         Female

      2. measurements

         1. group Id

            BG000

            value

            118

         2. group Id

            BG001

            value

            66

         3. group Id

            BG002

            value

            184

         title

         Male

   param Type

   COUNT_OF_PARTICIPANTS

   title

   Sex: Female, Male

   unit Of Measure

   Participants

3. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            value

            47

         2. group Id

            BG001

            value

            19

         3. group Id

            BG002

            value

            66

      title

      ASIAN

   2. categories

      1. measurements

         1. group Id

            BG000

            value

            3

         2. group Id

            BG001

            value

            1

         3. group Id

            BG002

            value

            4

      title

      BLACK OR AFRICAN AMERICAN

   3. categories

      1. measurements

         1. group Id

            BG000

            value

            162

         2. group Id

            BG001

            value

            84

         3. group Id

            BG002

            value

            246

      title

      WHITE

   4. categories

      1. measurements

         1. group Id

            BG000

            value

            6

         2. group Id

            BG001

            value

            3

         3. group Id

            BG002

            value

            9

      title

      NOT REPORTED

   param Type

   COUNT_OF_PARTICIPANTS

   title

   Race/Ethnicity, Customized

   unit Of Measure

   Participants

population Description

ITT Population

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice